88 related articles for article (PubMed ID: 11603272)
1. [Introduction of Synercid].
Régnier B
Presse Med; 2001 Sep; 30(25 Pt 2):IV. PubMed ID: 11603272
[No Abstract] [Full Text] [Related]
2. [Experimental models: interaction of Synercid with other anti-Gram positive agents].
Fantin B
Presse Med; 2001 Sep; 30(25 Pt 2):XV-XVIII. PubMed ID: 11603276
[TBL] [Abstract][Full Text] [Related]
3. Two new treatment options for infections due to drug-resistant gram-positive cocci.
Rehm SJ
Cleve Clin J Med; 2002 May; 69(5):397-401, 405-13. PubMed ID: 12022383
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological context: microbiological value of Synercid].
Etienne J
Presse Med; 2001 Sep; 30(25 Pt 2):VI-IX. PubMed ID: 11603273
[TBL] [Abstract][Full Text] [Related]
5. [Value of Synercid in clinical practice: from temporary approval to clinical trial authorization].
Potel G
Presse Med; 2001 Sep; 30(25 Pt 2):XIX-XXII. PubMed ID: 11603275
[TBL] [Abstract][Full Text] [Related]
6. [symbol: see text]Quinupristin + dalfopristin for infections.
Drug Ther Bull; 2002 Feb; 40(2):15-6. PubMed ID: 11892373
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
McNeil SA; Clark NM; Chandrasekar PH; Kauffman CA
Clin Infect Dis; 2000 Feb; 30(2):403-4. PubMed ID: 10671355
[No Abstract] [Full Text] [Related]
8. Antibiotic therapeutic options for infections caused by drug-resistant Gram-positive cocci.
Banwan K; Senok AC; Rotimi VO
J Infect Public Health; 2009; 2(2):62-73. PubMed ID: 20701863
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vancomycin-resistant Enterococcus faecium infections.
Lai KK
Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
[TBL] [Abstract][Full Text] [Related]
10. Introduction: treatment of Gram-positive infections.
Wise R
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii5-7. PubMed ID: 12797336
[No Abstract] [Full Text] [Related]
11. Quinupristin/dalfopristin.
Med Lett Drugs Ther; 1999 Nov; 41(1066):109-10. PubMed ID: 10987009
[No Abstract] [Full Text] [Related]
12. Study on the in-vitro activity of LY333328 against gram-positive cocci.
Mezzatesta ML; Bonfiglio G; De Angelis L; Stefani S; Russo G
J Antimicrob Chemother; 1998 Aug; 42(2):266-8. PubMed ID: 9738850
[No Abstract] [Full Text] [Related]
13. Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
Schweiger ES; Scheinfeld NS; Tischler HR; Weinberg JM
J Drugs Dermatol; 2003 Aug; 2(4):378-83. PubMed ID: 12884459
[TBL] [Abstract][Full Text] [Related]
14. Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections.
Frippiat F; Meunier F; Derue G
J Antimicrob Chemother; 2004 Dec; 54(6):1158; author reply 1159. PubMed ID: 15498877
[No Abstract] [Full Text] [Related]
15. Quinupristin-dalfopristin and linezolid: evidence and opinion.
Eliopoulos GM
Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
[TBL] [Abstract][Full Text] [Related]
16. What is the role of streptogramins in intensive care?
De Gaudio AR; Di Filippo A
J Chemother; 2003 Nov; 15 Suppl 3():17-21. PubMed ID: 14708961
[TBL] [Abstract][Full Text] [Related]
17. Glycopeptide-resistant Gemella haemolysans from blood.
Reed C; Efstratiou A; Morrison D; Woodford N
Lancet; 1993 Oct; 342(8876):927-8. PubMed ID: 8105186
[No Abstract] [Full Text] [Related]
18. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
Sgarabotto D; Cusinato R; Narne E; Scano F; Zignol M; Gambino A; Cattelan A; Meneghetti F; Cadrobbi P
Scand J Infect Dis; 2002; 34(2):122-6. PubMed ID: 11928842
[TBL] [Abstract][Full Text] [Related]
19. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
Linden PK; Moellering RC; Wood CA; Rehm SJ; Flaherty J; Bompart F; Talbot GH;
Clin Infect Dis; 2001 Dec; 33(11):1816-23. PubMed ID: 11668430
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Lundstrom TS; Sobel JD
Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
